Displaying 145 - 156 of 228
Metabolism, Alcohol & Toxicity

Tools for early detection of metabolic risk in MAFLD

Webcasts
View
Metabolism, Alcohol & Toxicity

Insights from the SIRIUS project – a population-wide liver disease screening program in Slovakia

Webcasts
View
Metabolism, Alcohol & Toxicity

Early screening of metabolic risk – the pharmacists’ perspective

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Sanofi: "Global Liver Health Forum 2023" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

To what extent can HRQoL impact clinical outcomes in MAFLD?

Webcasts
View
Metabolism, Alcohol & Toxicity

Essential phospholipids in the liver health landscape – clinical evidence

Webcasts
View
Metabolism, Alcohol & Toxicity

MAFLD – the importance of early identification and interventio

Webcasts
View
Metabolism, Alcohol & Toxicity

MAFLD-associated metabolic risks in obesity and diabetes – insights from clinical practice

Webcasts
View
General Hepatology

The burden of hepatic encephalopathy

Webcasts
View
Metabolism, Alcohol & Toxicity

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" (Complete Session)

Webcasts
View
Displaying 145 - 156 of 228